Pharma Investments, Ventures & Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures & Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Isolagen, Inc.
Isolagen, Inc. Announces Filing of Voluntary Petition Under Chapter 11 of the Bankruptcy Code
July 5th, 2009
Isolagen(TM), Inc. (NYSE Amex: ILE) announced that on June 15, 2009, the Company and Isolagen Technologies, Inc., the Company's wholly owned subsidiary, each filed a voluntary petition for reorganization under chapter 11 of the United States Bankruptcy Code in the United States Bankruptcy Court for the District of Delaware in Wilmington. The Company and Isolagen Technologies intend to continue to manage and operate their business as debtors in possession pursuant to the Bankruptcy Code. On June 10, 2009, the Company received a notice from the NYSE Amex that it intends to delist the Company's common stock from listing on the NYSE Amex, which delisting determination will...
Source: Pharma Investments, Ventures & Law Weekly (2009-07-05)
|
